NVSEF OTC
Novartis AG
1W: -4.8%
1M: -14.4%
3M: -15.2%
YTD: -2.8%
1Y: +6.6%
3Y: +40.6%
5Y: +89.8%
$134.20
-6.73 (-4.78%)
Weekly Expected Move ±9.8%
$108
$121
$134
$147
$160
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$115.5B
+13.0% ▲
5Y CAGR: -2.6%
Total Liabilities
$69.0B
+18.7% ▲
5Y CAGR: -1.8%
Shareholders Equity
$46.1B
+4.7% ▲
5Y CAGR: -4.0%
Cash & Investments
$11.6B
-13.2% ▼
5Y CAGR: +0.0%
Total Debt
$37.0B
+18.4% ▲
5Y CAGR: -0.6%
Net Debt
$25.6B
+29.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $12.4B | $7.5B | $13.4B | $11.5B | $11.4B |
| Short-Term Investments | $15.9B | $11.4B | $680M | $1.9B | $155M |
| Cash & ST Investments | $28.3B | $18.9B | $14.1B | $13.4B | $11.6B |
| Net Receivables | $8.8B | $8.9B | $8.1B | $9.5B | $10.9B |
| Inventory | $6.7B | $7.2B | $5.9B | $5.7B | $6.3B |
| Other Current Assets | $1.7B | $2.0B | $1.3B | $118M | $514M |
| Total Current Assets | $45.7B | $36.9B | $30.5B | $29.7B | $30.4B |
| Property, Plant & Equip. | $13.1B | $12.2B | $10.9B | $10.8B | $12.3B |
| Goodwill & Intangibles | $63.8B | $60.9B | $44.9B | $51.7B | $54.9B |
| Long-Term Investments | $3.2B | $2.6B | $1.8B | $1.1B | $2.3B |
| Other Non-Current Assets | $2.2B | $1.1B | $11.8B | $4.5B | $5.4B |
| Total Non-Current Assets | $86.1B | $80.5B | $69.5B | $72.5B | $85.1B |
| Total Assets | $131.8B | $117.5B | $99.9B | $102.2B | $115.5B |
| — Liabilities — | |||||
| Accounts Payable | $5.6B | $5.1B | $4.9B | $4.6B | $4.5B |
| Short-Term Debt | $6.3B | $5.9B | $6.1B | $8.1B | $5.5B |
| Deferred Revenue | $123M | $123M | $98M | $127M | $0 |
| Other Current Liabilities | $12.9B | $11.9B | $9.9B | $10.4B | $12.8B |
| Total Current Liabilities | $30.2B | $28.7B | $26.4B | $28.7B | $27.3B |
| Long-Term Debt | $22.9B | $20.2B | $18.4B | $21.4B | $29.6B |
| Other Non-Current Liab. | $4.5B | $4.9B | $4.5B | $4.1B | $2.5B |
| Total Non-Current Liabilities | $33.8B | $29.4B | $26.8B | $29.4B | $41.7B |
| Total Liabilities | $64.0B | $58.0B | $53.2B | $58.1B | $69.0B |
| — Equity — | |||||
| Common Stock | $901M | $890M | $825M | $791M | $765M |
| Retained Earnings | $70.9B | $63.6B | $49.6B | $46.5B | $44.7B |
| Accumulated OCI | -$4.2B | -$5.0B | -$3.8B | -$3.3B | $694M |
| Total Stockholders Equity | $67.7B | $59.3B | $46.7B | $44.0B | $46.1B |
| Total Liabilities & Equity | $131.8B | $117.5B | $99.9B | $102.2B | $115.5B |
| — Key Metrics — | |||||
| Total Debt | $31.1B | $28.0B | $26.3B | $31.3B | $37.0B |
| Net Debt | $18.7B | $20.4B | $13.0B | $19.8B | $25.6B |
| Total Investments | $19.2B | $14.0B | $2.4B | $3.0B | $2.5B |